Fluvakrish Injection
Product Info
| Prescription required | Yes |
| Marketer | Murli Krishna Pharma Pvt Ltd |
| Active Ingredient | Fulvestrant (50mg) |
| Storage | Store in a refrigerator (2 - 8°C). Do not freeze. |
| Chemical Class | Estrogens Derivatives |
| Habit Forming | No |
| Therapeutic Class | ANTI NEOPLASTICS |
| Action Class | Estrogen receptor antagonist |
| User Rating | 4.7 |
| User Reviews | 486 |
FAQ
What is Fluvakrish and what is it used for?
Fluvakrish contains a medicine, Fulvestrant which is used to treat breast cancer in women who have gone through menopause.
How and in what dose should I use Fluvakrish?
Your doctor would advise you the exact dose of this medicine. It is given as a slow (1 to 2 minutes) intramuscular (deep into the muscle) injection in your buttocks. It is administered by a medical healthcare professional only.
What are the common side effects of using Fluvakrish?
The common side effects associated with this medicine are headache, vomiting, urinary tract infection, diarrhea, vaginal bleeding, low platelets count and back pain. If any of these side effects bother you, consult with your doctor.
What if you forget to take Fluvakrish?
If you miss a dose of Fluvakrish, please consult your doctor.\n
Fluvakrish Injection Reviews
Fluvakrish is an estrogen blocker. It is used in the treatment of breast cancer in women who have gone through menopause. It works by adjusting the level of estrogen and slow down the growth of cancer cells.
Fluvakrish is given as an injection into the muscles under the supervision of a doctor. It should be taken as doctor your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.
The most common side effects of this medicine include injection site reaction, headache, vomiting, allergic reaction, and nausea. If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them.
Before taking this medicine, tell your doctor if you ever had kidney or liver disease or had bleeding disorder or had any blood clotting medicine. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.
Fluvakrish is given as an injection into the muscles under the supervision of a doctor. It should be taken as doctor your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.
The most common side effects of this medicine include injection site reaction, headache, vomiting, allergic reaction, and nausea. If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them.
Before taking this medicine, tell your doctor if you ever had kidney or liver disease or had bleeding disorder or had any blood clotting medicine. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.
How Fluvakrish Injection Works
Fluvakrish blocks the action of estrogen on breast cancer cells. This can lower or stop the growth of some breast cancer cells that need estrogen to grow.
How to Use Fluvakrish Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Benefits of Fluvakrish Injection
- In Breast cancer: Fluvakrish relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. It works by altering the production of those hormones in the body that are essential for the growth and spread of breast cancer. It may also interact with other hormones or have a direct effect on the cancer to stop its growth. It is given as an injection by a doctor or nurse and should not be self-administered. Follow your doctor’s instructions carefully.
Uses of Fluvakrish Injection
- Breast cancer
Fluvakrish Injection Side Effects
Safety Tips
Pregnancy
CONSULT YOUR DOCTOR
Fluvakrish is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Kidney
CAUTION
Fluvakrish should be used with caution in patients with severe kidney disease. Dose adjustment of Fluvakrish may be needed. Please consult your doctor.Limited information is available on the use of Fluvakrish in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Alcohol
CAUTION
Caution is advised when consuming alcohol with Fluvakrish. Please consult your doctor.
Driving
SAFE
Fluvakrish does not usually affect your ability to drive.
Breast feeding
UNSAFE
Fluvakrish is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Liver
CAUTION
Fluvakrish should be used with caution in patients with liver disease. Dose adjustment of Fluvakrish may be needed. Please consult your doctor.
Quick Tips
- Fluvakrish is used for the treatment of hormone dependent breast cancer.
- It should only be taken by women who have undergone menopause and cannot become pregnant.
- Do not take Fluvakrish if you are pregnant or breastfeeding.
- It is given as a slow injection into the muscles (intramuscular) of your buttock.
- Inform your doctor if you have any bleeding disorder, kidney or liver disease or if you are receiving any medicines to prevent blood clots.
References
- Drugs.com. Fulvestrant.
- Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1759-60.
- Central Drugs Standard Control Organisation (CDSCO).
- Fulvestrant. Luton, Bedfordshire: AstraZeneca UK Limited; 2004 [revised 6 Sep 2018].
- Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718.
- Fulvestrant. Cheshire, England: AstraZeneca UK Limited; 2002 [revised Jul. 2011].